Serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review
Tags
Data and Resources
To access the resources you must log in
This item has no data
Item URL
http://data.d4science.org/ctlg/RISIS2OpenData/dedup_wf_001--894fa6e4eac30083966620fef527156b |
|
Identity
Access Modality
Field | Value |
---|---|
Access Right | Restricted |
Attribution
Field | Value |
---|---|
Author | F. H. Van Bruggen |
Author | G. B. J. Nijhuis |
Author | S. U. Zuidema |
Author | Luijendijk, Hendrika |
Publishing
Field | Value |
---|---|
Collected From | figshare; Datacite; Crossref; Microsoft Academic Graph |
Hosted By | figshare; Expert Review of Clinical Pharmacology |
Journal | Expert Review of Clinical Pharmacology, 13, null |
Publication Date | 2020-01-01 |
Publisher | Informa UK Limited |
Additional Info
Field | Value |
---|---|
Language | Undetermined |
Resource Type | Other literature type; Article |
keyword | FOS: Sociology |
keyword | FOS: Chemical sciences |
keyword | keywords.General Pharmacology, Toxicology and Pharmaceutics |
system:type | publication |
Management Info
Field | Value |
---|---|
Source | https://science-innovation-policy.openaire.eu/search/publication?articleId=dedup_wf_001::894fa6e4eac30083966620fef527156b |
Author | jsonws_user |
Last Updated | 23 December 2020, 02:52 (CET) |
Created | 23 December 2020, 02:52 (CET) |